ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VEC Vectura Group Plc

164.80
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vectura Group Plc LSE:VEC London Ordinary Share GB00BKM2MW97 ORD 0.0271P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 164.80 164.80 165.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vectura Group plc Director Declaration (8894P)

31/05/2018 2:35pm

UK Regulatory


Vectura (LSE:VEC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Vectura Charts.

TIDMVEC

RNS Number : 8894P

Vectura Group plc

31 May 2018

VECTURA GROUP PLC (the "Company")

Chippenham, UK - 31 May 2018: Vectura Group plc (LSE: VEC) ("Vectura"), an industry-leading inhaled product formulation, device design and development business, announces that Frank Condella, Non-Executive Director, joined the Board of Mayne Pharma Group Limited, an ASX-listed specialty pharmaceutical company with effect from 30 May 2018.

This information is disclosed to the London Stock Exchange in accordance with the requirements under paragraph 9.6.14R of the United Kingdom Listing Rules relating to the disclosure of changes to the roles, functions and responsibilities of directors.

- Ends -

Enquiries

 
Vectura Group plc                                   +44 (0)20 7881 0524 
 
John Murphy 
 Company Secretary 
 
 
Consilium Strategic Communications                  +44 (0)20 3709 5700 
 
Mary-Jane Elliott / Susan Stuart/ Jessica Hodgson 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNFMGFKFMZGRZM

(END) Dow Jones Newswires

May 31, 2018 09:35 ET (13:35 GMT)

1 Year Vectura Chart

1 Year Vectura Chart

1 Month Vectura Chart

1 Month Vectura Chart

Your Recent History

Delayed Upgrade Clock